Tevogen Bio Holdings Inc. (TVGN): Nasdaq/NYSE listing notice — Semper Paratus receives Nasdaq delisting notice for unpaid fees of $151,000

Tevogen Bio Holdings Inc.

Notice received March 23, 2023 for failure to pay $151,000 in Nasdaq listing fees.
Trading of LGST, LGSTU, LGSTW to be suspended April 3, 2023 unless appeal is filed.
Company intends to pay outstanding balance and may appeal to a Nasdaq Hearings Panel.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Tevogen Bio Holdings Inc. received a nasdaq delisting notice notice regarding other (rules 5250(f)).

Exchange: nasdaq
Notice: delisting notice
Rules: 5250(f)

Exact text from the filing

ule or Standard; Transfer of Listing On March 23, 2023, Semper Paratus Acquisition Corp. (the “Company”) received a notice (the “Notice”) from the Listing Qualifications division of the Nasdaq Stock Market (“Nasdaq”) stating that the Company has not paid certain fees required by Nasdaq Listing Rule 5250(f) and that the Company will be delisted unless it appeals such determination. As of the date of the Notice, the Company’s past due fee balance totaled $151,000. If the Company elects not to appeal, trading of its Class A ordinary shares will be suspended at the opening of business on April 3

View on SEC.gov

2 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

Tevogen Bio Holdings Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-038333

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.